U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07544719) titled 'Systemic Immun Inflamation Score Corelation in Postoperative Patients Prognosis' on April 09.
Brief Summary: The Systemic Immuno-Inflammation Index (SII) is a ratio derived from complete blood count parameters (neutrophils, lymphocytes, platelets) and is a non-invasive and easily calculable biomarker. The SIPI effectively reflects both local and systemic inflammatory responses in the human body. It has been used to predict and evaluate the prognosis of various solid tumors such as gastric cancer, non-small cell lung cancer, and colorectal cancer. Furthermore, the SIPI has been shown to have significant prognostic value in cardiovas...